Literature DB >> 28133886

Somatic SNPs of the BRCA2 gene at the fragments encoding RAD51 binding sites of canine mammary tumors.

O Ozmen1, S Kul2, A Risvanli3, G Ozalp4, A Sabuncu5, O Kul6.   

Abstract

Mammary tumors are the most common tumor type both in women and in female dogs. In women, heritable breast cancers have been linked mutations in the breast cancer susceptibility gene BRCA2 and it contains eight BRC repeats in exon 11 that bind to RAD51. In this study, we investigated the sequence variations of BRC1-BRC8 and C-terminus of canine BRCA2 gene. From a total of 64 canine patients with mammary tumors, 31 mammary tumors with benign and malign carcinomas and the 3 normal mammary glands were used for the study. In this study, 19 SNPs of exon 11 of BRCA2 in canine mammary tumors were detected for the first time. The c.2383A>C (T1425P) SNP was found to be the most probable disease-associated nsSNP. Our findings suggest that T1425P variation in BRC3 to be the most probable disease-associated nsSNP and may affect RAD51 binding strength.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  BRCA2; CMT; RAD51; SNPs; dog

Mesh:

Substances:

Year:  2017        PMID: 28133886     DOI: 10.1111/vco.12293

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  4 in total

1.  Validation of AmpliSeq NGS Panel for BRCA1 and BRCA2 Variant Detection in Canine Formalin-Fixed Paraffin-Embedded Mammary Tumors.

Authors:  Daniela Di Giacomo; Marco Di Domenico; Sabrina Vanessa Patrizia Defourny; Daniela Malatesta; Giovanni Di Teodoro; Michele Martino; Antonello Viola; Nicola D'Alterio; Cesare Cammà; Paola Modesto; Antonio Petrini
Journal:  Life (Basel)       Date:  2022-06-07

Review 2.  Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy.

Authors:  Pauline Thumser-Henner; Katarzyna J Nytko; Carla Rohrer Bley
Journal:  BMC Vet Res       Date:  2020-01-31       Impact factor: 2.741

3.  Identification of the core motif of the BRCA2 C-terminal RAD51-binding domain by comparing canine and human BRCA2.

Authors:  Yasunaga Yoshikawa; Masami Morimatsu; Kazuhiko Ochiai; Toshina Ishiguro-Oonuma; Ryo Morioka; Kento Okuda; Koichi Orino
Journal:  J Vet Med Sci       Date:  2021-03-16       Impact factor: 1.267

Review 4.  DNA damage response proteins in canine cancer as potential research targets in comparative oncology.

Authors:  Beatriz Hernández-Suárez; David A Gillespie; Aleksandra Pawlak
Journal:  Vet Comp Oncol       Date:  2022-01-10       Impact factor: 2.385

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.